Quarterly report [Sections 13 or 15(d)]

Segment Information (Tables)

v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Information The following table presents segment information for the periods presented (in thousands):
Three Months Ended March 31,
2026 2025
Total Revenues $ 58,818  $ 53,333 
Less:
Employee related expenses 21,002  19,538 
Commercial related expenses 7,040  5,339 
Outside clinical trial related expenses 6,927  4,371 
Cost of product sales 4,606  4,409 
Consultants and third-party services 4,006  3,409 
Other segment items 3,352  3,494 
Interest expense, net 228  1,262 
Provision for income taxes 3,003  65 
Segment income $ 8,654  $ 11,446